Risk factors for recurrence of acute gastrointestinal bleeding from angiodysplasia

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 12, 2009, Pages 1333-1339

  Saperas, Esteve ^a   Videla, Sebastián ^a   Dot, Joan ^a   Bayarri, Carolina ^a   Lobo, Beatriz ^a   Abu Suboh, Monder ^a   Armengol, Jose Ramón ^a   Malagelada, Juan R ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Angiodysplasia; Endoscopic therapy; Gastrointestinal bleeding; Gastrointestinal haemorrhage

Indexed keywords

ACUTE DISEASE; AGED; ANGIODYSPLASIA; ANTICOAGULANT THERAPY; ARGON PLASMA COAGULATION; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANGIODYSPLASIA; ARGON PLASMA COAGULATION; EPIDEMIOLOGIC METHODS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 77950206269     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32830e491c     Document Type: Article

References (36)

1. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993; 88: 807-818.
2. Clouse R, Costigan D, Millis B, Zuckerman G. Angiodysplasia as a cause of upper gastrointestinal bleeding. Arch Intern Med 1985; 145: 458-461.
3. Richter JM, Christensen MR, Colditz GA, Nishioka NS. Angiodysplasia. Natural history and efficacy of therapeutic interventions. Dig Dis Sci 1989; 34: 1542-1546.
4. Gupta N, Longo WE, Vernava AM III. Angiodysplasia of the lower gastrointestinal tract: an entity readily diagnosed by colonoscopy and primarily managed nonoperatively. Dis Colon Rectum 1995; 38: 979-982.
5. Zuckerman GR, Prakash C. Acute lower intestinal bleeding. Part II: etiology, therapy and outcomes. Gastrointest Endose 1999; 49: 228-238.
6. Van Cutsem E, Rutgeerts P, Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 1990; 335: 953-955.
7. Lewis B, Salomon P, Rivera-MacMurray S, Kornbluth AA, Wenger J, Waye JD. Does hormonal therapy have any benefit for bleeding angiodysplasia. J Clin Gastroenterol 1992; 15: 99-103.
8. Junquera F, Feu F, Papo M, Videla S, Saperas E, Bordas JM, et al. A multicenter randomized controlled clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001; 121: 1073-1079.
9. Rutgeerts P, Van Gompel F, Geboes K, Van Trappen G, Boreckaert L, Coremans G. Long term results of treatment of vascular malformations of the gastrointestinal tract by neudymium Yag laser photocoagulation. Gut 1985; 26: 586-593.
10. Mathus-Vliegen EM. Laser treatment of intestinal vascular abnormalities. Int J Colorectal Dis 1989; 4: 20-25.
11. Gostout CJ, Bowyer BA, Ahlquist DA, Viggiano TR, Balm RK. Mucosal vascular malformations of the gastrointestinal tract: clinical observations and results of endoscopic neodymium: yttrium-aluminum-garnet laser therapy. Mayo Clin Proc 1988; 63: 993-1003.
12. Naveau S, Aubert A, Poynard T, Chaput JC. Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation. Dig Dis Sci 1990; 35: 821-826.
13. Sargeant IR, Loizou LA, Rampton D, Tulloch M, Bown SG. Laser ablation of upper gastrointestinal vascular: long term results. Gut 1993; 34: 470-475.
14. Pavey DA, Craig PI. Endoscopic therapy for upper-GI vascular ectasias. Gastrointest Endose 2004; 59: 233-238.
15. Morris AJ, Mokhashi M, Straiton M, Murray L, Mackenzie JF. Push enteroscopy and heater probe therapy for small bowel bleeding. Gastrointest Endose 1996; 44: 394-397.
16. Askin MP, Lewis BS. Push enteroscope cauterization: long-term follow-up of 83 patients with bleeding small intestinal angiodysplasia. Gastrointest Endose 1996; 43: 580-583.
17. Vakil N, Huilgol V, Khan I. Effect of push enteroscopy on transfusion requirements and quality of life in patients with unexplained gastrointestinal bleeding. Am J Gastroenterol 1997; 92: 425-428.
18. Schmit A, Gay F, Adler M, Cremer M, Van Gossum A. Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias. Dig Dis Sci 1996; 41: 2348-2352.
19. Landi B, Cellier C, Gaundric M, Demont H, Guimbaud R, Cuillerier E, et al. Long-term outcome of patients with gastrointestinal bleeding of obscure origin explored by push enteroscopy. Endoscopy 2002; 34: 355-359.
20. Johanns W, Luis W, Janssen K, Kahl S, Greiner L. Argon plasma coagulation (APC) in gastroenterology: experimental and clinical experiences. Eur J Gastroenterol Hepatol 1997; 9: 581-587.
21. Johanns W, Jakobeit C, Luis W, Greiner L. Long-term outcome of argon plasma coagulation therapy for bleeding. Dig Liver Dis 2003; 35: 806-810.
22. Olmos JA, Marcolongo M, Pogorelsky V, Varela E, Davolos JR. Argon plasma coagulation for prevention of recurrent bleeding from GI angiodysplasias. G/E2004; 60: 881-886.
23. Olmos JA, Marcolongo M, Pogorelsky V, Herrera L, Tobal L, Davolos JR. Long-term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia. Dis Colon Rectum 2006; 49: 1507-1516.
24. Kwan V, Bourke MJ, Williams SJ, Gillespie PE, Murray MA, Kaffes AJ, et al. Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up. Am J Gastroenterol 2006; 101: 58-63.
25. Imperiale TF, Ransohoff DF Aortic stenosis, idiopathic gastrointestinal bleeding, and angiodysplasia: is there an association? A methodologie critique of the literature. Gastroenterology 1988; 95: 1670-1676.
26. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet 1992; 340: 35-37.
27. Warkentin TE, Moore JC, Anand SS, Lonn EM, Morgan DG. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev 2003; 4: 272-286.
28. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349: 343-349.
29. lkuta T, Shibata T, Hirai H, Fukui T, Suehiro S. Small-intestinal bleeding from angiodysplasia after aortic valve replacement. J Heart Valve Dis 2003; 12: 458-460.
30. Giovannini I, Chiaria C, Murazio M, Clemente G, Giuliante F, Nuzzo G. An extreme case of Heyde syndrome. Dig Surg 2006; 23: 387-388.
31. Nardone G, Rocco A, Balzano T, Budillon G. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999; 13: 1429-1436.
32. Junquera F, Saperas E, Videla S, Feu F, Vilaseca J, Armengol JR, et al. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Am J Gastroenterol 2007; 102: 254-260.
33. Junquera F, Saperas E, Torres I, Vidal T, Malagelada JR. Increased expression of angiogenic factors in human colonic angiodyplasia. Am J Gastroenterol 1999; 94: 1070-1076.
34. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci 1994; 91: 4082-4085.
35. Shurafa M, Kamboj G. Thalidomide for the treatment of bleeding angiodysplasias. Am J Gastroenterol 2003; 98: 221-222.
36. Bauditz J, Schachschal G, Wedel SS, Lochs H. Thalidomide for treatment of severe intestinal bleeding. Gut 2004; 53: 609-612.